Cite
Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341.
MLA
Fang, Yong, et al. “Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341.” Cancer Investigation, vol. 29, no. 4, May 2011, pp. 247–52. EBSCOhost, https://doi.org/10.3109/07357907.2010.496756.
APA
Fang, Y., Hu, Y., Wu, P., Wang, B., Tian, Y., Xia, X., Zhang, Q., Chen, T., Jiang, X., Ma, Q., Xu, G., Wang, S., Zhou, J., Ma, D., & Meng, L. (2011). Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341. Cancer Investigation, 29(4), 247–252. https://doi.org/10.3109/07357907.2010.496756
Chicago
Fang, Yong, Yi Hu, Peng Wu, Beibei Wang, Yuan Tian, Xi Xia, Qinghua Zhang, et al. 2011. “Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341.” Cancer Investigation 29 (4): 247–52. doi:10.3109/07357907.2010.496756.